QT shortening: a proarrhythmic safety surrogate measure or an inappropriate indicator of it?

References

• Rudy Y. Molecular basis of cardiac action potential repolarization. Ann N Y Acad Sci. 2008;1123:113–118.
   PubMed Web of Science ®Google Scholar
• Cain JW, Schaeffer DG. Shortening of cardiac action potential duration near an insulating boundary. Math Med Biol. 2008;25(1):21–36.
   PubMed Web of Science ®Google Scholar
• Postema PG, Wilde AA. The measurement of the QT interval. Curr Cardiol Rev. 2014;10(3):287–294.
   PubMedGoogle Scholar
• Rezuş C, Moga VD, Ouatu A, et al. QT interval variations and mortality risk: is there any relationship? Anatol J Cardiol. 2015;15(3):255–258.
   PubMed Web of Science ®Google Scholar
• Raschi E, Poluzzi E, Koci A, et al. QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus. Br J Clin Pharmacol. 2011;72(5):839–841.
   PubMed Web of Science ®Google Scholar
• Tse G, Chan YW, Keung W, et al. Electrophysiological mechanisms of long and short QT syndromes. Int J Cardiol Heart Vasc. 2017;14:8–13.
   PubMed Web of Science ®Google Scholar
• Tekin A, Tekin G, Sezgin AT, et al. Short- and long-term effect of simvastatin therapy on the heterogeneity of cardiac repolarization in diabetic patients. Pharmacol Res. 2008;57(5):393–397.
   PubMed Web of Science ®Google Scholar
• Ozkanlar Y, Nishijima Y, da Cunha D, et al. Acute effects of tacrolimus (FK506) on left ventricular mechanics. Pharmacol Res. 2005;52(4):307–312.
   PubMed Web of Science ®Google Scholar
• Couderc JP, Lopes CM. Short and long QT syndromes: does QT length really matter? J Electrocardiol. 2010;43(5):396–399.
   PubMed Web of Science ®Google Scholar
• Shah RR, Bjerregaard P, Gussak I. Drug-induced QT interval shortening: an emerging component in integrated assessment of cardiac safety of drugs. J Electrocardiol. 2010;43(5):386–389.
   PubMed Web of Science ®Google Scholar
• Shah R. Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives. Br J Pharmacol. 2010;159(1):58–59.
   PubMed Web of Science ®Google Scholar
• Malik M. Drug-Induced QT/QTc interval shortening: lessons from Drug-Induced QT/QTc prolongation. Drug Saf. 2016;39(7):647–659.
   PubMed Web of Science ®Google Scholar
• ICH S7B. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. The non-clinical evaluation of the potential for delayed ventricular repolarisation (QT interval prolongation) by human pharmaceuticals. 2005; [cited 2017 Dec 11]. Available from: https://database.ich.org/sites/default/files/S7B_Guideline.pdf.
   Google Scholar
• ICH E14. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs. 2005; [cited 2022 May 11]. Available from: https://database.ich.org/sites/default/files/E14_Guideline.pdf.
   Google Scholar
• EudraVigilance Expert Working Group. Guideline on the use of statistical signal detection methods in the EudraVigilance Data Analysis System. 2008; [cited 2017 Oct 11]. Available from: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guideline-use-statistical-signal-detection-methods-eudravigilance-data-analysis-system_en.pdf.
   Google Scholar
• Bégaud B, Evreux JC, Jouglard J, et al. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie. 1985;40(2):111–118.
   PubMed Web of Science ®Google Scholar
• Krysiak R, Okopie B. Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2. Wiad Lek. 2012;65(4):239–242.
   PubMedGoogle Scholar
• Takahashi K, Nakayashiro M, Ganaha H. Dual atrioventricular nodal non-reentrant tachycardia in a child undergoing repair of ventricular septal defect. Pediatr Cardiol. 2013;34(3):715–718.
   PubMed Web of Science ®Google Scholar
• Chhabra L, Spodick DH. Milk alkali syndrome: an electrocardiographic masquerader for non-hypothermic osborn phenomenon. Heart. 2013;99(17):1302–1303.
   PubMed Web of Science ®Google Scholar
• Yamamoto T. A study of carbamazepine-induced arrhythmogenic effects. The 64th Annual Meeting of the Japanese Society of National Medical Services. 2010:530.
   Google Scholar
• Gheshlaghi F, Yaraghi A, Soh EH, et al. Relationship of cardiovascular complications with level of consciousness in patients with acute carbamazepine intoxication. Med Arh. 2012;66(1):9–11.
   PubMedGoogle Scholar
• Grande I, Pons A, Baeza I, et al. QTc prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment. Hum Psychopharmacol. 2011;26(6):397–403.
   PubMed Web of Science ®Google Scholar
• Ahmed SH, et al. Digitalis toxicity, hyperkalemia, and acute renal failure. South Med J. 2001;94(12):S15–S16.
   Google Scholar
• Spodick DH. Atrial tachycardia with AV nodal wenckebach in digitalis excess. Am J Geriatr Cardiol. 2002;11(2):126.
   PubMedGoogle Scholar
• Zvenigorodskaia LA. Stubborn nausea and not ease vomiting as a manifestation of glycoside toxicity in a patient with duodenal ulcer and gastric erosions in the background of Ebstein’s anomaly. Exp Clin gastroenterol. 2010;2:59–63.
   Google Scholar
• Ishimaru T, Yokogawa H. Olfactory and gustatory disturbances caused by digitalism: a case report. Auris Nasus Larynx. 2006;33(4):465–469.
   PubMed Web of Science ®Google Scholar
• Romeo E, D’Alto M, Santarpia G, et al. Hyperkalemia-induced conversion of permanent atrial fibrillation to normal sinus rhythm: a case report. J Cardiovasc Med. 2011;12(9):678–680.
   Google Scholar
• Morariu M. Atrial arrhythmias: the unrecognized side of digitalis overdose. Rom J Cardiol. 2014;2014:62.
   Google Scholar
• Petrou E, Tsipis A, Vartela V. Athanassopoulos G. Electrocardiogram quiz – case 27. Arch Hell Med. 2016;33(1):137–138.
   Google Scholar
• Spila B. Combined treatment with sertindole and clozapine for patients with drug-resistast schizophrenia. Farmakoterapia w Psychiatrii i Neurologii. 2012;2:87–93.
   Google Scholar
• Shoja Shafti S, Fallah Jahromi P. A comparative study between olanzapine and risperidone regarding drug-induced electrocardiographic changes. Cardiovasc Psychiatry Neurol. 2014;2014:637016.
   PubMedGoogle Scholar
• Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol. 1991;32(2):143–149.
   PubMed Web of Science ®Google Scholar
• Nielsen AS, Damek DM. Window of opportunity: flexion myelopathy after drug overdose. J Emerg Med. 2012;42(1):36–39.
   PubMed Web of Science ®Google Scholar
• Lu JJ. Dramatic QTc narrowing after intralipid administration in quetiapine overdose. Clinical toxicology. 2009;47(7):740.
   Web of Science ®Google Scholar
• Oechsner M, Korchounov A. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson’s disease? Hum Psychopharmacol. 2005;20(3):203–205.
   PubMed Web of Science ®Google Scholar